摘要
静脉血栓栓塞性疾病是恶性肿瘤的常见并发症之一,尤其是对于接受化学治疗的患者,其发生率更高。静脉血栓栓塞性疾病可引发致命性后果,从而增加恶性肿瘤患者的死亡率。本文拟对恶性肿瘤、化学治疗与静脉血栓栓塞性疾病的关系作一总结,并对其临床表现、治疗、预后进行综述,以期提高认识,做好防治工作。
Venous thromboembolism disease （VTED） is one of the most common complications of malignancies. Moreover, a higher incidence of VTED has been recorded in cancer patients who had chemotherapy. As VTED can result in lethal outcome, such as fatal pulmonary embolism, the mortality will increase obviously in those patients with malignant tumors and VTED simultaneously. For the purpose of preventing and managing this important complication in time, we carried out this review to analyse the rela- tionship of malignancy, chemotherapy and venous thromh^mbohsm disease, as well as the clinical mani- festations, diagnosis and treatment of this special setting.
出处
《肿瘤药学》
CAS
2011年第3期162-165,共4页
Anti-Tumor Pharmacy
基金
中南大学2009年米塔尔创新项目(09MX18)
关键词
恶性肿瘤
化疗
静脉血栓栓塞性疾病
Malignancy
Chemotherapy
Venous Thromboembohsm Disease
